ETFS Holding Biogen Idec Inc

 
ETFS Holding Biogen Idec Inc top ^
  • Holdings: Top Holdings IBB More..., Regeneron Pharmaceuticals, Inc., Gilead Sciences Inc, Amgen Inc, Celgene Corporation, Biogen Idec Inc
  • Category: Health
  • Morningstar Rating: 4 Stars
Sign-up for ibb investment picks
  • Holdings: Top Holdings QQQE More..., Vertex Pharmaceuticals, Akamai Technologies, Inc., Regeneron Pharmaceuticals, Inc., Biogen Idec Inc, Microsoft Corporation
  • Category: Large Growth
Sign-up for qqqe investment picks
  • Holdings: Top Holdings RYH More..., Actavis Inc, Regeneron Pharmaceuticals, Inc., Biogen Idec Inc, AbbVie Inc, WellPoint Inc
  • Category: Health
  • Morningstar Rating: 3 Stars
Sign-up for ryh investment picks
  • Holdings: Top Holdings PBE More..., Regeneron Pharmaceuticals, Inc., Biogen Idec Inc, Gilead Sciences Inc, Life Technologies Corp, Amgen Inc
  • Category: Health
  • Morningstar Rating: 2 Stars
Sign-up for pbe investment picks
  • Holdings: Top Holdings QQEW More..., Amgen Inc, Dollar Tree Stores, Inc., Biogen Idec Inc, Nuance Communications, Inc., Gilead Sciences Inc
  • Category: Large Growth
  • Morningstar Rating: 4 Stars
Sign-up for qqew investment picks
  • Holdings: Top Holdings FBT More..., Biogen Idec Inc, Gilead Sciences Inc, Amgen Inc, Nektar Therapeutics, Inc., Incyte Corp Ltd
  • Category: Health
  • Morningstar Rating: 3 Stars
Sign-up for fbt investment picks
  • Holdings: Top Holdings PTH More..., Regeneron Pharmaceuticals, Inc., Biogen Idec Inc, AbbVie Inc, Amgen Inc, Thermo Fisher Scientific Inc
  • Category: Health
  • Morningstar Rating: 2 Stars
Sign-up for pth investment picks
  • Holdings: Top Holdings QQXT More..., Amgen Inc, Dollar Tree Stores, Inc., Biogen Idec Inc, Gilead Sciences Inc, Mondelez International Inc
  • Category: Large Growth
  • Morningstar Rating: 5 Stars
Sign-up for qqxt investment picks
  • Holdings: Top Holdings BBH More..., Amgen Inc, Gilead Sciences Inc, Celgene Corporation, Biogen Idec Inc, Alexion Pharmaceuticals, Inc.
  • Category: Health
Sign-up for bbh investment picks

 
Stock Quotes for Biogen Idec Inc top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Large Growth
  • Stock Type: Aggressive Growth
  • Morningstar Rating: 2 Stars
Sign-up for biib investment picks

 
News Articles for Biogen Idec Inc top ^
2013/3/6
Biogen Idec (NASDAQ: BIIB) will present more than 50 company-sponsored platform and poster presentations on data supporting its multiple-marketed and pipeline therapies for neurological diseases at the 65 th American Academy of Neurology (AAN) Annual Meeting in San Diego, March 16-23, 2013.
Sign-up for Biogen Idec to Present New Data on Diverse Neurological Portfolio at 65th AAN Annual Meeting investment picks
2013/3/4
Biogen Idec (NASDAQ: BIIB) announced today that the U.S. Food and Drug Administration (FDA) has accepted the company’s Biologics License Application (BLA) for the marketing approval of recombinant factor IX Fc fusion protein (rFIXFc) for the treatment of hemophilia B and granted the company a standard review timeline.
Sign-up for FDA Accepts Biogen Idec’s Biologics License Application for First Long-Lasting Factor IX Therapy for Hemophilia B investment picks
2013/2/27
Biogen Idec Inc.  (NASDAQ: BIIB) announced today that it will present at the Cowen and Company 33 rd Annual Healthcare Conference.
Sign-up for Biogen Idec to Present at the Cowen and Company 33rd Annual Healthcare Conference investment picks
2013/2/15
The Cambridge Science Festival (CSF) today announced “Biogen Idec Foundation Science on the Street,” a new statewide, year-round outreach initiative to bring engaging science, technology, engineering, and math (STEM) demonstrations and activities to thousands of people annually.
Sign-up for Cambridge Science Festival Announces Statewide Year-Round Science Outreach Initiative: Biogen Idec Foundation Science on the Street investment picks
2013/2/20
Biogen Idec Inc.  (NASDAQ: BIIB) announced today that it will present at the 2013 RBC Capital Markets Global Healthcare Conference.
Sign-up for Biogen Idec to Present at the 2013 RBC Capital Markets Global Healthcare Conference investment picks
2013/3/12
Biogen Idec (NASDAQ: BIIB) announced today that the company has submitted a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for the marketing approval of recombinant factor VIII Fc fusion protein (rFVIIIFc) for the treatment of hemophilia A.
Sign-up for Biogen Idec Submits Application to FDA for First Long-Lasting Factor VIII Therapy for Hemophilia A investment picks
2013/3/20
Today Biogen Idec (NASDAQ: BIIB) announced the positive, full first-year results from its two-year pivotal Phase 3 ADVANCE study of PLEGRIDY™ (peginterferon beta-1a), the company’s investigational candidate for relapsing-remitting multiple sclerosis (RRMS) dosed once every two weeks or every four weeks.
Sign-up for Positive Year One Results from Biogen Idec Phase 3 ADVANCE Trial of PLEGRIDY™ (Peginterferon Beta-1a) Presented at AAN Meeting investment picks
2013/3/27
Today Biogen Idec (NASDAQ: BIIB) announced that the U.S. Food and Drug Administration (FDA) has approved TECFIDERA™ (dimethyl fumarate), a new first-line oral treatment for people with relapsing forms of multiple sclerosis (MS). Biogen Idec will make this oral capsule available to people living with MS in the United States in the coming days.
Sign-up for Biogen Idec’s TECFIDERA™ (Dimethyl Fumarate) Approved in US as a First-Line Oral Treatment for Multiple Sclerosis investment picks
2013/4/2
Elan Corporation, plc (NYSE:ELN) is pleased to announce the closing today of the TYSABRI ® (natalizumab) Collaboration Transaction with Biogen Idec.
Sign-up for Elan Announces Closing of TYSABRI® Collaboration Transaction with Biogen Idec investment picks
2013/4/2
Biogen Idec (NASDAQ: BIIB) today announced it has completed its purchase of Elan Corporation’s interest in TYSABRI ® (natalizumab) and has gained full strategic, commercial and decision-making rights to TYSABRI.
Sign-up for Biogen Idec Completes Purchase of Full Rights and Control of TYSABRI® investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

ETFS Holding Biogen Idec Inc
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: ETFS Holding Bill Barrett Corporation  |  Next: ETFS Holding Biomarin Pharmaceutical, Inc.